NCT05231655View on ClinicalTrials.gov

Ex VIvo DEtermiNed Cancer Therapy

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions
Bladder CancerKidney CancerMelanomaSarcomaGlioblastomaHead and Neck Cancer
Interventions
DIAGNOSTIC_TEST

Functional drug screen

High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles

Trial Locations (1)

S10 2JF

RECRUITING

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

All Listed Sponsors
collaborator

University of Sheffield

OTHER

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER